Literature DB >> 29506057

Preexposure Prophylaxis Initiation and Retention in Care Over 5 Years, 2012-2017: Are Quarterly Visits Too Much?

Laura K Rusie1, Carlos Orengo1, Diane Burrell1, Arthi Ramachandran2,3,4, Magda Houlberg1, Kristin Keglovitz1, David Munar1, John A Schneider1,2,3,4.   

Abstract

Retention in preexposure prophylaxis (PrEP) care is critical to elimination of human immunodeficiency virus. We reviewed all Howard Brown Health patients receiving PrEP (n = 5583) from 2012 to 2017. Among those with 12 months of follow-up, 43% remained in care, yet only 15% had all 4 quarters with a PrEP visit. Insurance status and comorbid conditions were drivers of retention in care.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29506057      PMCID： PMC7190936          DOI： 10.1093/cid/ciy160

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  9 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  Potential Healthcare Insurance and Provider Barriers to Pre-Exposure Prophylaxis Utilization Among Young Men Who Have Sex with Men.

Authors:  Sarah J Marks; Roland C Merchant; Melissa A Clark; Tao Liu; Joshua G Rosenberger; Jose Bauermeister; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2017-11       Impact factor: 5.078

3.  An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.

Authors:  Sybil G Hosek; Bret Rudy; Raphael Landovitz; Bill Kapogiannis; George Siberry; Brandy Rutledge; Nancy Liu; Jennifer Brothers; Kathleen Mulligan; Gregory Zimet; Michelle Lally; Kenneth H Mayer; Peter Anderson; Jennifer Kiser; James F Rooney; Craig M Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

4.  A paradigm shift: focus on the HIV prevention continuum.

Authors:  Margaret L McNairy; Wafaa M El-Sadr
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

5.  Measuring retention in HIV care: the elusive gold standard.

Authors:  Michael J Mugavero; Andrew O Westfall; Anne Zinski; Jessica Davila; Mari-Lynn Drainoni; Lytt I Gardner; Jeanne C Keruly; Faye Malitz; Gary Marks; Lisa Metsch; Tracey E Wilson; Thomas P Giordano
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

Review 6.  From access to engagement: measuring retention in outpatient HIV clinical care.

Authors:  Michael J Mugavero; Jessica A Davila; Christa R Nevin; Thomas P Giordano
Journal:  AIDS Patient Care STDS       Date:  2010-10       Impact factor: 5.078

7.  High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.

Authors:  Stephanie E Cohen; Eric Vittinghoff; Oliver Bacon; Susanne Doblecki-Lewis; Brian S Postle; Daniel J Feaster; Tim Matheson; Nikole Trainor; Robert W Blue; Yannine Estrada; Megan E Coleman; Richard Elion; Jose G Castro; Wairimu Chege; Susan S Philip; Susan Buchbinder; Michael A Kolber; Albert Y Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

8.  No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

Authors:  Jonathan E Volk; Julia L Marcus; Tony Phengrasamy; Derek Blechinger; Dong Phuong Nguyen; Stephen Follansbee; C Bradley Hare
Journal:  Clin Infect Dis       Date:  2015-09-01       Impact factor: 9.079

9.  Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities.

Authors:  Philip A Chan; Leandro Mena; Rupa Patel; Catherine E Oldenburg; Laura Beauchamps; Amaya G Perez-Brumer; Sharon Parker; Kenneth H Mayer; Matthew J Mimiaga; Amy Nunn
Journal:  J Int AIDS Soc       Date:  2016-06-13       Impact factor: 5.396
  9 in total
  40 in total

1.  Implementation Research Methodologies for Achieving Scientific Equity and Health Equity.

Authors:  Moira McNulty; J D Smith; Juan Villamar; Inger Burnett-Zeigler; Wouter Vermeer; Nanette Benbow; Carlos Gallo; Uri Wilensky; Arthur Hjorth; Brian Mustanski; John Schneider; C Hendricks Brown
Journal:  Ethn Dis       Date:  2019-02-21       Impact factor: 1.847

2.  Decisional Balance and Contemplation Ladder to Support Interventions for HIV Pre-Exposure Prophylaxis Uptake and Persistence.

Authors:  Steven A John; H Jonathon Rendina; Tyrel J Starks; Christian Grov; Jeffrey T Parsons
Journal:  AIDS Patient Care STDS       Date:  2019-01-17       Impact factor: 5.078

3.  PrEP Implementation and Persistence in a County Health Department Setting in Atlanta, GA.

Authors:  Charlotte-Paige Rolle; Udodirim Onwubiko; Jennifer Jo; Anandi N Sheth; Colleen F Kelley; David P Holland
Journal:  AIDS Behav       Date:  2019-10

4.  Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation.

Authors:  Matthew A Spinelli; Susan P Buchbinder
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

5.  Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.

Authors:  Matthew A Spinelli; David V Glidden; Peter L Anderson; Monica Gandhi; Stephanie Cohen; Eric Vittinghoff; Megan E Coleman; Hyman Scott; Oliver Bacon; Richard Elion; Michael A Kolber; Susan P Buchbinder; Albert Y Liu
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

6.  Low tenofovir level in urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demonstration project.

Authors:  Matthew A Spinelli; David V Glidden; Warren C Rodrigues; Guohong Wang; Michael Vincent; Hideaki Okochi; Karen Kuncze; Megha Mehrotra; Patricia Defechereux; Susan P Buchbinder; Robert M Grant; Monica Gandhi
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

7.  Out-of-pocket costs and HIV pre-exposure prophylaxis persistence in a US multicity demonstration project.

Authors:  Nathan W Furukawa; John A Schneider; Megan E Coleman; Jeffrey B Wiener; Ram K Shrestha; Dawn K Smith
Journal:  Health Serv Res       Date:  2020-03-20       Impact factor: 3.402

8.  Pre-exposure Prophylaxis Uptake and Discontinuation Among Young Black Men Who Have Sex With Men in Atlanta, Georgia: A Prospective Cohort Study.

Authors:  David P Serota; Eli S Rosenberg; Patrick S Sullivan; Annie L Thorne; Charlotte-Paige M Rolle; Carlos Del Rio; Scott Cutro; Nicole Luisi; Aaron J Siegler; Travis H Sanchez; Colleen F Kelley
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

9.  A modeling framework to inform preexposure prophylaxis initiation and retention scale-up in the context of 'Getting to Zero' initiatives.

Authors:  Aditya S Khanna; John A Schneider; Nicholson Collier; Jonathan Ozik; Rodal Issema; Angela di Paola; Abigail Skwara; Arthi Ramachandran; Jeannette Webb; Russell Brewer; William Cunningham; Charles Hilliard; Santhoshini Ramani; Kayo Fujimoto; Nina Harawa
Journal:  AIDS       Date:  2019-10-01       Impact factor: 4.177

10.  Understanding PrEP Persistence: Provider and Patient Perspectives.

Authors:  Nicole D Laborde; Patrick M Kinley; Matthew Spinelli; Eric Vittinghoff; Ryan Whitacre; Hyman M Scott; Susan P Buchbinder
Journal:  AIDS Behav       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.